The Role of APRIL in IgA Nephropathy
Learn about the pathogenic process that causes kidney injury and about APRIL, an important initiating and sustaining driver in IgAN. Reference: Mathur M, et al. J Clin Med. 2023;12(21):6927. Read More
- About
- IgAN
- Events
- Resource Center
- Simulators
What interests you?+Help Us Enhance Your NephU ExperienceHelp Us Enhance Your NephU Experience
User experience form
Video
Quality of Life
Explore the impact of IgAN on a patient’s mental and emotional health with Dr Kalra. Learn more about the IgAN patient journey: References: Read MorePatient Presentation
Gain insight from Dr Colbert into how patients with IgAN typically present in the clinic. Learn more about the IgAN patient journey: References: Read MorePrognostic Tools
Learn from Dr Lerma about the MEST-C score and how it is used to assess the risk of IgAN progression. Learn more about the evolving clinical approach to IgAN: References: Read MoreGaps in Treatment
Examine gaps in the current IgAN treatment landscape with Dr Colbert. Learn more about the evolving clinical approach to IgAN: Read MoreTreatment Landscape
Explore the evolving treatment landscape of IgAN with Dr Colbert. Learn more about the evolving clinical approach to IgAN: Read MoreProteinuria
Gain insight into target proteinuria thresholds and their relevance in IgAN management from Dr Colbert. Learn more about IgAN pathophysiology: References: Read More4-Hit Process
Join Dr Lerma as he outlines the role of the 4-hit process in IgAN pathogenesis. Learn more about IgAN pathophysiology: References: Read MoreNephU is supported by Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC) and Otsuka America Pharmaceutical, Inc. (OAPI) - committed supporters of the kidney health community. The information provided through NephU is intended for the educational benefit of health care professionals and others who support care for those with kidney disease and other related conditions. It is not intended as, nor is it a substitute for, medical care, advice, or professional diagnosis. Health care professionals should use their independent medical judgement when reviewing NephU’s educational resources. Users seeking medical advice should consult with a health care professional. No CME or CEU credits are available through any of the resources provided by NephU. Some of the contributors may be paid consultants of OPDC and/or OAPI.©2025 Otsuka Pharmaceutical Development & Commercialization, Inc. All rights reserved. - IgAN
